Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity
Authors:
Open Access
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 119, 105368
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomasHuman Pathology, 2016
- Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung CancerJAMA Oncology, 2016
- Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patientsOncoImmunology, 2015
- Intramuscular Therapeutic Vaccination Targeting HPV16 Induces T Cell Responses That Localize in Mucosal LesionsScience Translational Medicine, 2014
- CD4+ follicular helper T cell infiltration predicts breast cancer survivalJournal of Clinical Investigation, 2013
- Unique Ectopic Lymph Node-Like Structures Present in Human Primary Colorectal Carcinoma Are Identified by Immune Gene Array ProfilingThe American Journal of Pathology, 2011
- US FDA Perspective on Challenges in Co-Developing In Vitro Companion Diagnostics and Targeted Cancer TherapeuticsBioanalysis, 2011
- Overall survival and PD‐L1 expression in metastasized malignant melanomaCancer, 2010
- GenePattern 2.0Nature Genetics, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005